Cue biopharma announces public offering

Cue Biopharma ( NASDAQ: CUE ) said on Monday that it is commencing an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of common stock. Shares of CUE slipped -12.76% to $0.

69 during extended trading. Source: Press Release More on Cue Biopharma Seeking Alpha’s Quant Rating on Cue Biopharma Historical earnings data for Cue Biopharma Financial information for Cue Biopharma.